Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Biolase Technology Inc.

Sep 2011
Dental laser manufacturer Biolase Technology Inc. of Irvine, Calif., has received two more patents from the US Patent and Trademark Office for its laser technologies that treat various eye conditions, including presbyopia – the decline of near vision in midlife. The patents are the seventh and eighth to be issued under the “Methods for Treating Eye Conditions” patent family. US Patent number 7,967,017 includes 29 claims and introduces a strategy for identifying optimal treatment zones for the reversal of presbyopia. US Patent No. 7,909,040 includes 10 claims and relates to the shape of the treatment laser beam and specific ablative patterns for treating the condition.

A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
Americasbiolase technologyBiophotonicsBusinessCaliforniadental laserslaser ablative patternslaser beamslasersMethods for Treating Eye Conditionsnear-vision losspatent number 7909040patent number 7967017presbyopiaRapidScanUS Patent and Trademark Office

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!